Close Menu

NEW YORK, Jan. 16 (GenomeWeb News) - AstraZeneca will extend its use of InforSense's informatics platform, InforSense said today.

 

InforSense, based in London, will build a new Open Discovery Workflow platform at AstraZeneca's research site in Molndal, Sweden, which will be accessed by researchers at several AstraZeneca sites.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.